欢迎来到三一办公! | 帮助中心 三一办公31ppt.com(应用文档模板下载平台)
三一办公
全部分类
  • 办公文档>
  • PPT模板>
  • 建筑/施工/环境>
  • 毕业设计>
  • 工程图纸>
  • 教育教学>
  • 素材源码>
  • 生活休闲>
  • 临时分类>
  • ImageVerifierCode 换一换
    首页 三一办公 > 资源分类 > PPT文档下载
     

    ACCFAHA成人心力衰竭诊断和治疗指南解读文档资料.ppt

    • 资源ID:4682323       资源大小:677KB        全文页数:50页
    • 资源格式: PPT        下载积分:10金币
    快捷下载 游客一键下载
    会员登录下载
    三方登录下载: 微信开放平台登录 QQ登录  
    下载资源需要10金币
    邮箱/手机:
    温馨提示:
    用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)
    支付方式: 支付宝    微信支付   
    验证码:   换一换

    加入VIP免费专享
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    ACCFAHA成人心力衰竭诊断和治疗指南解读文档资料.ppt

    2009 ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults:A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,Developed in Collaboration With:International Society for Heart and Lung Transplantation,Initial Clinical Assessment of Patients Presenting With Heart Failure,Recommendations for the Initial Clinical Assessment of Patients Presenting With Heart Failure,Identifying and Evaluating Noncardiac Disorders or Behaviors,Initial Assessment and Examination of Patients With HF,Recommendations for the Initial Clinical Assessment of Patients Presenting With Heart Failure,Initial Laboratory Evaluation,Recommendations for the Initial Clinical Assessment of Patients Presenting With Heart Failure,Two-Dimensional Echocardiography,Recommendations for the Initial Clinical Assessment of Patients Presenting With Heart Failure,Coronary Revascularization,Recommendations for the Initial Clinical Assessment of Patients Presenting With Heart Failure,Noninvasive Imaging and Exercise Testing,Recommendations for the Initial Clinical Assessment of Patients Presenting With Heart Failure,Initial Clinical Assessment of Patients Presenting With Heart Failure,Endomyocardial Biopsy,Initial Clinical Assessment of Patients Presenting With Heart Failure,Measurement of BNP and Noninvasive Imaging,Documenting Ventricular Tachycardia Inducibility,Initial Clinical Assessment of Patients Presenting With Heart Failure,Measuring Circulating Levels of Neurohormones,Initial Clinical Assessment of Patients Presenting With Heart Failure,Patients With Reduced Left Ventricular Ejection Fraction,Patients With Reduced Left Ventricular Ejection Fraction,Measures listed as Class I recommendations for patients in Stages A and B are also appropriate for patients in Stage C.,Measuring LVEF,Patients With Reduced Left Ventricular Ejection Fraction,Measuring LVEF,Patients With Reduced Left Ventricular Ejection Fraction,NO CHANGE,Angiotensin ll Receptor Blockers,Patients With Reduced Left Ventricular Ejection Fraction,Secondary Prevention:Implantable Cardioverter-Defibrillator,Patients With Reduced Left Ventricular Ejection Fraction,Primary Prevention:Implantable Cardioverter-Defibrillator,Patients With Reduced Left Ventricular Ejection Fraction,Resynchronization Therapy,Patients With Reduced Left Ventricular Ejection Fraction,The Risks of Aldosterone Antagonists,Patients With Reduced Left Ventricular Ejection Fraction,Recommendations for Hydralazine and Nitrates,Patients With Reduced Left Ventricular Ejection Fraction,Recommendations for Atrial Fibrillation and Heart Failure,Patients With Reduced Left Ventricular Ejection Fraction,Measurement of Respiratory Gas Exchange,Patients With Reduced Left Ventricular Ejection Fraction,The Benefits of Digitalis,Patients With Reduced Left Ventricular Ejection Fraction,Implantable Cardioverter-Defibrillator in Pts With Low LVEF,Patients With Reduced Left Ventricular Ejection Fraction,ARB and Conventional Therapy,Patients With Reduced Left Ventricular Ejection Fraction,Infusion of Positive Inotropic Drugs,Patients With Reduced Left Ventricular Ejection Fraction,Patients With Heart Failure and Normal Left Ventricular Ejection Fraction,Patients With Heart Failure and Normal Left Ventricular Ejection Fraction,Normal Left Ventricular Ejection Fraction,Patients With Heart Failure and Normal Left Ventricular Ejection Fraction,Normal Left Ventricular Ejection Fraction,Patients With Heart Failure and Normal Left Ventricular Ejection Fraction,Normal Left Ventricular Ejection Fraction,Recommendations for the Hospitalized PatientNew Recommendations,The diagnosis of heart failure is primarily based on signs and symptoms derived from a thorough history and physical exam.Clinicians should determine the following:a.adequacy of systemic perfusion;b.volume status;c.the contribution of precipitating factors and/or co-morbidities d.if the heart failure is new onset or an exacerbation of chronic disease;ande.whether it is associated with preserved normal or reduced ejection fraction.Chest radiographs,electrocardiogram and echocardiography are key tests in this assessment.,The Hospitalized Patient,The Hospitalized Patient,Patients Being Evaluated for Dyspnea,The Hospitalized Patient,Precipitating Factors for Acute HF,The Hospitalized Patient,Oxygen Therapy and Rapid Intervention,The Hospitalized Patient,Treatment With Intravenous Loop Diuretics,The Hospitalized Patient,Monitoring and Measuring Fluid Intake and Output,The Hospitalized Patient,Intensifying the Diuretic Regimen,Invasive hemodynamic monitoring should be performed to guide therapy in patients who are in respiratory distress or with clinical evidence of impaired perfusion in whom the adequacy or excess of intracardiac filling pressures cannot be determined from clinical assessment.,In patients with clinical evidence of hypotension associated with hypoperfusion and obvious evidence of elevated cardiac filling pressures(e.g.,elevated jugular venous pressure;elevated pulmonary artery wedge pressure),intravenous inotropic or vasopressor drugs should be administered to maintain systemic perfusion and preserve end-organ performance while more definitive therapy is considered.,The Hospitalized Patient,Preserving End-Organ Performance,New,New,The Hospitalized Patient,Reconciling and Adjusting Medications,Medications should be reconciled in every patient and adjusted as appropriate on admission to and discharge from the hospital.,In patients with reduced ejection fraction experiencing a symptomatic exacerbation of HF requiring hospitalization during chronic maintenance treatment with oral therapies known to improve outcomes,particularly ACE inhibitors or ARBs and beta-blocker therapy,it is recommended that these therapies be continued in most patients in the absence of hemodynamic instability or contraindications.,New,New,The Hospitalized Patient,The Hospitalized Patient,The Hospitalized Patient,The Hospitalized Patient,Severe Symptomatic Fluid Overload,Invasive hemodynamic monitoring can be useful for carefully selected patients with acute HF who have persistent symptoms despite empiric adjustment of standard therapies,and a.whose fluid status,perfusion,or systemic orpulmonary vascular resistances are uncertain;b.whose systolic pressure remains low,pr is associated with symptoms,despite initialtherapy;c.whose renal function is worsening with therapy;d.who require parenteral vasoactive agents;ore.who may need consideration for advanced device therapy or transplantation.,The Hospitalized Patient,Invasive Hemodynamic Monitoring,Ultrafiltration is reasonable for patients with refractory congestion not responding to medical therapy.,The Hospitalized Patient,Intravenous inotropic drugs such as dopamine,dobutamine or milrinone might be reasonable for those patients presenting with documented severe systolic dysfunction,low blood pressure and evidence of low cardiac output,with or without congestion,to maintain systemic perfusion and preserve end-organ performance.,Ultrafiltration and Intravenous Inoptropic Drugs,New,New,The Hospitalized Patient,Parenteral Inotropes,49,Thank you for your attention,

    注意事项

    本文(ACCFAHA成人心力衰竭诊断和治疗指南解读文档资料.ppt)为本站会员(sccc)主动上传,三一办公仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知三一办公(点击联系客服),我们立即给予删除!

    温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载不扣分。




    备案号:宁ICP备20000045号-2

    经营许可证:宁B2-20210002

    宁公网安备 64010402000987号

    三一办公
    收起
    展开